Sub-Community 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Siblings 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] Community Statistics 近3年內發表的文件:335(13.91%) 含全文筆數:2250(93.40%) 文件下載次數統計 下載大於0次:2250(100.00%) 下載大於100次:2250(100.00%) 檔案下載總次數:1611277(30.06%) 最後更新時間: 2024-11-28 18:37 Top Upload Loading... Top Download Loading... Recent Submissions Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1601-1625 of 2409. (97 Page(s) Totally) << < 60 61 62 63 64 65 66 67 68 69 > >> View [10|25|50] records per page

Date	Title	Relation
2012-01-20	TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer	Journal of Biological Chemistry. 2012 Jan 20;287(4):2798-2809.
2012-01	Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method	Environmental and Molecular Mutagenesis. 2012 Jan;53(1):22-31.
2012-01	Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families	British Journal of Cancer. 2012 Jan;106(1):206-209.
2012-01	Long-term results of a randomized, observation-controlled, phase III trial of adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection	Annals of Surgery. 2012 Jan;255(1):8-17.
2012-01	Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides	Oncology Reports. 2012 Jan;27(1):238-245.
2012-01	Epstein-Barr virus Rta-mediated transactivation of p21 and 14-3-3sigma arrests cells at the G1/s transition by reducing cyclin E/CDK2 activity	Journal of General Virology. 2012 Jan;93(1):139-149.
2012-01	NBM-HD-1: A novel histone deacetylase inhibitor with anticancer activity	Evidence-based Complementary and Alternative Medicine. 2012 Jan;2012:Article ID 781417.
2012-01	Impact of age on end-of-life care for adult Taiwanese cancer decedents, 2001-2006	Palliative Medicine. 2012 Jan;26(1):80-88.
2012-01	Caffeic acid phenethyl ester causes p21Cip1 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells	PLoS ONE. 2012 Jan;7(2):Article number e31286.
2012-01	Edema index-guided disease management improves 6-month outcomes of patients with acute heart failure	International Heart Journal. 2012 Jan;53(1):11-17.
2011-12-22	5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Part 2. The impact of bridging groups at position C-2	Journal of Medicinal Chemistry. 2011 Dec 22;54(24):8517-8525.
2011-12-16	Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan	BMC Infectious Diseases. 2011 Dec 16;11:Article number 352.
2011-12-15	Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors	Free Radical Biology and Medicine. 2011 Dec 15;51(12):2195-2209.
2011-12	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	International Journal of Radiation Oncology, Biology, Physics. 2011 Dec;81(5):e749-e757.
2011-12	t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement	Cancer Chemotherapy and Pharmacology. 2011 Dec;68(6):1387-1395.
2011-12	Hydrolysable tannins of tropical almond show antifibrotic effects in TGF-beta1-induced hepatic stellate cells	Journal of the Science of Food and Agriculture. 2011 Dec;91(15):2777-2784.
2011-12	Loss of lactate dehydrogenase B subunit expression is correlated with tumour progression and independently predicts inferior disease-specific survival in urinary bladder urothelial carcinoma	Pathology. 2011 Dec;43(7):707-712.
2011-11-15	Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo	Clinical Cancer Research. 2011 Nov 15;17(22):7116-7126.
2011-11-15	Coumarin compounds and their use for treating cancer	US8058427B2/2011-11-15
2011-11-11	Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation [Erratum: Biochemical and Biophysical Research Communications. 2011 Jun;409(3):442-447.]	Biochemical and Biophysical Research Communications. 2011 Nov 11;415(1):213.
2011-11-01	Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells	Molecular BioSystems. 2011 Nov 1;7(11):3065-3074.
2011-11	Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine	Supportive Care in Cancer. 2011 Nov;19(11):1779-1787.
2011-11	Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc	Cancer Science. 2011 Nov;102(11):2022-2028.
2011-11	Bioimaging analysis of nuclear factor-kappa B activity in Philadelphia chromosome-positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor-alpha-stimulated changes to the microenvironment	Cancer Science. 2011 Nov;102(11):2014-2021.
2011-11	Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma	Genes Chromosomes and Cancer. 2011 Nov;50(11):908-921.

Showing items 1601-1625 of 2409. (97 Page(s) Totally) << < 60 61 62 63 64 65 66 67 68 69 > >> View [10|25|50] records per page